Evidence map›Paper›PMID 33298153›Full record

ArticleParasites & vectors2020

IPSE, a urogenital parasite-derived immunomodulatory molecule, suppresses bladder pathogenesis and anti-microbial peptide gene expression in bacterial urinary tract infection.

Evaristus C Mbanefo, Loc Le, Luke F Pennington, Yi- Ju Hsieh, Justin I Odegaard, Kristina Lapira, Theodore S Jardetzky, Franco H Falcone, Michael H Hsieh

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. DoesCells · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 3 countries.

Evaristus C MbanefoDivision of Urology, Department of Surgery, Children's National Hospital, West Wing, 4th Floor, 111 Michigan Avenue NW, Washington, DC, 20010, USA.
Loc LeBiomedical Research Institute, Rockville, MD, USA.
Luke F PenningtonDepartment of Structural Biology, Stanford University, Stanford, CA, USA.
Yi- Ju HsiehBiomedical Research Institute, Rockville, MD, USA.
Justin I OdegaardGuardant Health, Redwood City, CA, USA.
Kristina LapiraUniversity of California San Diego, La Jolla, USA.
Theodore S JardetzkyDepartment of Structural Biology, Stanford University, Stanford, CA, USA.
Franco H FalconeInstitute of Parasitology, Justus-Liebig-Universität Gießen, Gießen, Germany.
Michael H HsiehDivision of Urology, Department of Surgery, Children's National Hospital, West Wing, 4th Floor, 111 Michigan Avenue NW, Washington, DC, 20010, USA. mhsieh@cnmc.org.ORCID http://orcid.org/0000-0002-9650-2691
Stanford University · USBiomedical Research Institute · USChildren's National · USFountain Biopharma (Taiwan) · TWGuardant (United States) · USJustus-Liebig-Universität Gießen · DENational Institutes of Health · USUniversity of California San Diego · US

Funding

Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity SyndromesR01DK113504 · NIDDK · CHILDREN'S RESEARCH INSTITUTE · PI HSIEH, MICHAEL HARRISON · 2017 to 2021
$2.4M
NIDDK NIH HHS R01 DK113504
6 · The paper itself

Abstract

backgroundParasitic infections can increase susceptibility to bacterial co-infections. This may be true for urogenital schistosomiasis and bacterial urinary tract co-infections (UTI). We previously reported that this co-infection is facilitated by S. haematobium eggs triggering interleukin-4 (IL-4) production and sought to dissect the underlying mechanisms. The interleukin-4-inducing principle from Schistosoma mansoni eggs (IPSE) is one of the most abundant schistosome egg-secreted proteins and binds to IgE on the surface of basophils and mast cells to trigger IL-4 release. IPSE can also translocate into host nuclei using a nuclear localization sequence (NLS) to modulate host transcription. We hypothesized that IPSE is the factor responsible for the ability of S. haematobium eggs to worsen UTI pathogenesis.

methodsMice were intravenously administered a single 25 μg dose of recombinant S. haematobium-derived IPSE, an NLS mutant of IPSE or PBS. Following IPSE exposure, mice were serially weighed and organs analyzed by histology to assess for toxicity. Twenty-four hours after IPSE administration, mice were challenged with the uropathogenic E. coli strain UTI89 by urethral catheterization. Bacterial CFU were measured using urine. Bladders were examined histologically for UTI-triggered pathogenesis and by PCR for antimicrobial peptide and pattern recognition receptor expression.

resultsUnexpectedly, IPSE administration did not result in significant differences in urine bacterial CFU. However, IPSE administration did lead to a significant reduction in UTI-induced bladder pathogenesis and the expression of anti-microbial peptides in the bladder. Despite the profound effect of IPSE on UTI-triggered bladder pathogenesis and anti-microbial peptide production, mice did not demonstrate systemic ill effects from IPSE exposure.

conclusionsOur data show that IPSE may play a major role in S. haematobium-associated urinary tract co-infection, albeit in an unexpected fashion. These findings also indicate that IPSE either works in concert with other IL-4-inducing factors to increase susceptibility of S. haematobium-infected hosts to bacterial co-infection or does not contribute to enhancing vulnerability to this co-infection.

Indexed as

Gene ExpressionImmunomodulationAnimalsBasophilsCoinfectionEgg ProteinsEscherichia coliFemaleHelminth ProteinsInterleukin-4MaleMiceMice, Inbred BALB CSchistosoma mansoniSchistosomiasis haematobiaUrinary BladderEgg ProteinsHelminth ProteinsInterleukin-4BladderHaematobiumIL-4IPSESchistosomaSchistosomeUrinary tract infectionα-1

Identifiers

PMID33298153
PMCPMC7724859
OpenAlexW3111466168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.